Radiosynthesis, In Vitro Validation, and In Vivo Evaluation of 18F-Labeled COX-1 and COX-2 Inhibitors
Timothy J. McCarthy, PhD1,
Ahmed U. Sheriff, MS1,
Matthew J. Graneto, BS2,
John J. Talley, PhD2 and
Michael J. Welch, PhD1
1 Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
2 Discovery Research, Pharmacia Corporation, St. Louis, Missouri

View larger version (11K):
[in a new window]
|
FIGURE 1. Structures of celecoxib (A) and rofecoxib (B).
|
|

View larger version (10K):
[in a new window]
|
FIGURE 2. Structures of SC63217 (A) and SC58125 (B).
|
|

View larger version (13K):
[in a new window]
|
FIGURE 3. Synthesis and radiosynthesis of 18F-SC58125 (compound 4a) and 18F-SC63217 (compound 4b).
|
|

View larger version (25K):
[in a new window]
|
FIGURE 4. In vitro study on accumulation of 18F-SC58125 in J774 macrophage cells. Results are shown as mean ± SD (n = 3).
|
|

View larger version (29K):
[in a new window]
|
FIGURE 5. In vitro study on accumulation of 18F-SC63217 in J774 macrophage cells. Results are shown as mean ± SD (n = 3).
|
|

View larger version (73K):
[in a new window]
|
FIGURE 6. Sample PET images obtained from injection of 18F-SC58125 into mature female baboon. (A) Summed images over first 30 min after injection. (B) Summed images from 1 to 2 h after injection.
|
|
Copyright © 2002 by the Society of Nuclear Medicine.